Phosphoinositide 3-kinases (PI3Ks) are cellular lipid kinases that phosphorylate the 3-position hydroxyl group of the inositol ring of phosphatidylinositol to generate the lipid second messenger phosphatidylinositol 3,4,5-triphosphate. [23] [24] [25] Studies have focused on class I PI3Ks, comprising the class IA (p110α, β, and δ) and class IB (p110γ, encoded Background-The integrity of endothelial monolayer is a sine qua non for vascular homeostasis and maintenance of tissuefluid balance. However, little is known about the signaling pathways regulating regeneration of the endothelial barrier after inflammatory vascular injury. Methods and Results-Using genetic and pharmacological approaches, we demonstrated that endothelial regeneration selectively requires activation of p110γPI3K signaling, which thereby mediates the expression of the endothelial reparative transcription factor Forkhead box M1 (FoxM1). We observed that FoxM1 induction in the pulmonary vasculature was inhibited in mice treated with a p110γ-selective inhibitor and in Pik3cg −/− mice after lipopolysaccharide challenge. Pik3cg −/− mice exhibited persistent lung inflammation induced by sepsis and sustained increase in vascular permeability. Restoration of expression of either p110γ or FoxM1 in pulmonary endothelial cells of Pik3cg −/− mice restored endothelial regeneration and normalized the defective vascular repair program. We also observed diminished expression of p110γ in pulmonary vascular endothelial cells of patients with acute respiratory distress syndrome, suggesting that impaired p110γ-FoxM1 vascular repair signaling pathway is a critical factor in persistent leaky lung microvessels and edema formation in the disease. 
T he integrity of endothelial monolayer is a sine qua non for vascular homeostasis and maintenance of tissue-fluid balance. 1, 2 The key function of the endothelial barrier is to maintain fluid balance between the blood plasma and interstitium. 3, 4 Endothelial injury results in most of the complications associated with inflammation: increased vascular permeability to protein, diapedesis of erythrocytes and transmigration of inflammatory cells, tissue edema, and microthrombi formation. [5] [6] [7] In acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), vascular endothelial injury leads to extravasation of neutrophils and monocytes and accumulation and intractability of protein-rich edema. [8] [9] [10] After vascular injury, repair of the endothelial monolayer through activation of intrinsic endothelial repair programs is a prerequisite for restoring vascular homeostasis.
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Clinical Perspective on p 1103
Endothelial regeneration occurs as a result of endothelial proliferation and reannealing of endothelial junctions to form the characteristic restrictive endothelial barrier. 11, [15] [16] [17] We showed that Forkhead box M1 (FoxM1), belonging to the fox family of transcriptional factors sharing homology in winged helix DNA-binding domains, 18 is required for vascular endothelial regeneration. 11 FoxM1 mediated G1/S and G2/M transition secondary to transcriptional control of cell cycle progression genes. [19] [20] [21] [22] FoxM1 expression was upregulated in endothelial cells (ECs) only during the repair phase after vascular injury induced by lipopolysaccharide (LPS). 11 In mice with EC-restricted disruption of FoxM1, endothelial barrier recovery after LPS challenge was severely impaired as a result of defective EC proliferation 11 and reannealing of endothelial adherens junctions.
by Pik3cg) isoforms. Class IA kinases forming a complex with SH2-conatining regulatory p85-related subunits are in general activated through receptor tyrosine kinases, whereas class IB, p110γ, is activated by G protein-coupled receptors (GPCRs) through its regulatory subunit p101 or p84 and G-protein subunits. 24, 25 p110β Is also activated by GPCR signaling in p110γ-deficient cells. 26 p110γ is expressed in leukocytes and at low levels in ECs and smooth muscle cells. In neutrophils, eosinophils, and macrophages, p110γ mediates chemokine-induced migration of these cells. 27, 28 It has been shown that p110γ plays an important role in the initial inflammatory responses (at 1 or 6 hours after challenge) to sepsis challenge via regulating neutrophil recruitment and migration. 29, 30 However, little is known about the role of p110γ in regulating endothelial regeneration and vascular repair during the repair phase. Here, we focused on the fundamental role of endothelial p110γ on the basis of our observation that p110γ expression was markedly reduced in pulmonary vascular ECs of patients with ARDS (see Results). In the mouse model of endotoxemia, we demonstrated that p110γ deficiency severely impaired vascular repair after LPS challenge and that restoration of endothelial expression of either p110γ or FoxM1 normalized defective endothelial regeneration in Pik3cg −/− mice. Thus, selectively targeting p110γ to promote FoxM1-mediated vascular repair represents a novel therapeutic strategy for the treatment of inflammatory vascular diseases such as ALI.
Methods
Please see the online-only Data Supplement for full details of the methods used.
Mice
Pik3cg
−/− mice were obtained from Dr Joseph Penninger (Amgen Institute, Toronto, ON, Canada). 29, 31 FoxM1 transgenic mice were obtained from Dr Robert H. Costa at the University of Illinois College of Medicine (Chicago). 20 Littermate wild-type (WT) mice (C57BL/6 background) were used as controls. All mice were bred and maintained in the Association for Assessment and Accreditation of Laboratory Animal Care-accredited animal facilities at the University of Illinois at Chicago according to National Institutes of Health guidelines. All animal experiments were performed in accordance with protocols approved by the University of Illinois at Chicago Animal Care and Use Committee.
Human Lung Tissues
Human lung tissues were obtained from patients with ARDS (n=6) and unused donor lungs (n=8) under the supervision of Kurt Albertine. Informed consents and approval from the Ethics Committee of the University of Utah (Institutional Review Board No. 5632) were obtained before tissue collection.
Statistical Analysis
Data are expressed as mean±SD. Statistical significance was determined by 1-way ANOVA with a Games-Howell post hoc analysis for multiple-group comparisons. Two-group comparisons were analyzed by the 2-tailed unpaired Student t test or Mann-Whitney (nonparametric) test, depending on the data distribution. Statistical analysis of the mortality study was performed with the log-rank (Mantel-Cox) test. The P values are 2 sided. Values of P<0.05 denoted the presence of a statistically significant difference.
An expanded Materials and Methods section containing detailed descriptions of the induction of polymicrobial sepsis, lung transvascular albumin flux assessment, scanning electron microscopy, intravital microscopy, myeloperoxidase assay, histology and imaging, in situ cell proliferation and apoptosis assay, primary cultures of human lung microvascular ECs, molecular analysis, and liposome-mediated transduction of cDNA into mouse lung vascular ECs is provided in the online-only Data Supplement.
Results p110γPI3K Isoform Mediates FoxM1 Expression in the Pulmonary Vasculature
We first used the pan-PI3K inhibitor wortmannin to determine the role of PI3K signaling in regulating FoxM1 expression in the pulmonary vasculature after inflammatory injury. At 12 hours after LPS challenge, WT mice were treated with wortmannin (0.05 mg/kg body weight IP every 12 hours) or the vehicle dimethyl sulfoxide (DMSO). There was little FoxM1 induction at 24 hours after LPS challenge in lungs of either DMSO-or wortmannin-treated mice, whereas FoxM1 mRNA expression in DMSO-treated lungs was upregulated at 48 and 72 hours after LPS ( Figure 1A ). This time course directly paralleled the time course of lung vascular repair seen in this model. 11 Western blotting demonstrated decreased FoxM1 protein expression in the wortmannin-treated mice ( Figure 1B) .
To identify the PI3K isoform mediating FoxM1 upregulation, mice were treated at 12 hours after LPS challenge 32 or AS-605240, a p110γ inhibitor. 33 Quantitative real-time reverse transcription-polymerase chain reaction (QRT-PCR) analysis showed that only p110γ inhibition decreased FoxM1 expression at 72 hours after LPS ( Figure 1C ). Using lungs from Pik3cg −/− mice, we confirmed that FoxM1 expression was inhibited after LPS in these lungs ( Figure 1D ). These data demonstrate that FoxM1 induction in the pulmonary vasculature after LPS challenge selectively requires the p110γPI3K isoform.
p110γ Is Required for Vascular Repair After Endotoxin-Induced Lung Inflammation
We next determined alterations in vascular permeability by assessing pulmonary transvascular flux of Evans Blueconjugated albumin (EBA). 34 EBA flux increased 3-to 4-fold and peaked within 24 hours after LPS challenge in Pik3cg −/− lungs, similar to WT lungs ( Figure 2A ). EBA flux in WT lungs returned to basal levels at 60 hours after LPS, indicating full recovery, whereas Pik3cg −/− lungs exhibited persistent vascular leakiness, indicating defective vascular repair. Lung microvascular integrity was also examined by scanning electron microscopy after vessels were filled with the tracer methyl methacrylate. At 60 hours after LPS challenge, WT lungs had minimal tracer extravasation, as seen in WT and Pik3cg −/− lungs basally, whereas Pik3cg −/− lungs exhibited striking leakage ( Figure 2B) Figure 3A and 3B). Lung myeloperoxidase activity 11 showed similar neutrophil infiltration in WT and Pik3cg −/− lungs during the injury phase up to 24 hours after LPS, except p110γ deficiency induced an early decrease in neutrophil infiltration at 2 hours after LPS ( Figure 3C and Figure II in the onlineonly Data Supplement). By 48 hours after LPS challenge, myeloperoxidase activity in WT lungs returned to basal level, whereas myeloperoxidase activity in Pik3cg −/− lungs remained elevated ( Figure 3C ). QRT-PCR analysis demonstrated increased expression of intracellular adhesion molecule-1 and proinflammatory cytokines, as well as induced nitric oxide synthase, at 48 hours after LPS in Pik3cg −/− lungs ( Figure 3D -3G), consistent with persistence of lung inflammation in Pik3cg −/− mice. Given that p110γ deficiency itself affects the initial neutrophil recruitment after LPS challenge ( Figure II in the online-only Data Supplement), we treated WT mice with the p110γ inhibitor at 12 hours after LPS challenge. As shown in Figure III in the online-only Data Supplement, p110γ inhibitor-treated mice exhibited lung vascular permeability and inflammation responses at 24 hours after LPS challenge similar to those of controls. However, the p110γ inhibitor-treated mice showed greater EBA extravasation and myeloperoxidase activity at 48 hours after LPS challenge, supporting the role of p110γ deficiency in impairing the lung vascular repair program. We also performed real-time intravital microscopy to assess vascular permeability in live animals. FITCconjugated dextran was injected through the tail vein, and the cremaster muscle was then exteriorized onto an intravital microscopy tray to image the vascular permeability of cremaster muscle venules. As shown in Figure 2D and 2E, Pik3cg −/− mice exhibited basal permeability similar to that of WT and Pg −/− /Tg mice. However, at 48 hours after LPS challenge, Pik3cg −/− mice exhibited a marked increase in vascular permeability compared with WT mice, whereas Pg −/− /Tg mice exhibited vascular permeability similar to that seen in WT mice. These data suggest that p110γ-mediated vascular repair via FoxM1 is a generalized process after inflammatory vascular injury.
p110γ Signaling of FoxM1 Expression Reduces Lung Inflammation
To determine whether persistent lung inflammation in Pik3cg −/− mice was also the result of decreased FoxM1 expression, we assessed leukocyte infiltration and myeloperoxidase activity in Pg 
p110γ Is Required for Endothelial Regeneration
We next determined whether p110γ-induced FoxM1 expression was required for EC proliferation as measured by BrdU incorporation. 11 As shown in Figure 4A and 4B, WT mouse lungs exhibited marked increase in cell proliferation at 72 hours after LPS compared with WT lungs at baseline, as previously shown elsewhere. 11 However, we observed decreased cell proliferation in Pik3cg −/− mouse lungs, which was the result of reduced EC proliferation, as demonstrated by colocalization /Tg lungs, however, significantly increased the expression of these genes, indicating that FoxM1 is the effector of p110γ-mediated EC proliferation in vivo.
Restoration of EC Expression of p110γ Induces FoxM1 Expression and Endothelial Regeneration in
Pik3cg −/− Lungs
We next used liposome-mediated gene transduction 15 to address whether forced expression of p110γ in pulmonary vascular ECs of Pik3cg −/− mice will reverse the defective vascular repair. Transduction of plasmid DNA expressing human p110γ under the control of the 3.5kb CDH5 (encoding VE-cadherin) promoter 35 −/− mice is ascribed to diminished expression of p110γ in ECs, whereas impaired neutrophil recruitment and migration during the early response to LPS challenge are attributable to p110γ deficiency in neutrophils.
We next addressed whether restoration of endothelial p110γ expression in Pik3cg −/− mouse lungs induced FoxM1 expression and thereby endothelial regeneration after injury. In the Pik3cg −/− lungs in which p110γ had been restored in ECs, FoxM1 mRNA expression was induced similarly in WT lungs ( Figure 5F ). The downstream targets of FoxM1 responsible for cell cycle progression, Cdc25C and cyclin B1, were also upregulated in these lungs, in contrast to the control Pik3cg −/− mouse lungs ( Figure 5G and 5H) . BrdU labeling demonstrated a normal proliferation rate in the mouse lung ECs in which p110γ was introduced ( Figure 5I and Figure  VII in the online-only Data Supplement). These data demonstrate that endothelial expression of p110γ is required for FoxM1 induction and the resultant endothelial regeneration after inflammatory vascular injury. 
EC Expression of FoxM1 in
p110γ-Mediated FoxM1 Expression Is Required for Lung Vascular Repair in Septic Mice
We next addressed the pathophysiological relevance of these findings using the mouse cecal ligation and puncture (CLP) model, which causes polymicrobial septicemia accompanied by ALI. CLP similarly increased pulmonary vascular EBA flux at 24 hours after challenge in WT, Pik3cg 
p110γ Expression Is Diminished in Pulmonary Vascular ECs of ARDS Patients
To further address the clinical relevance of these observations in mice to the pathogenesis of ARDS in patients, we examined p110γ protein levels in lung sections from patients with ARDS. 36 As shown in Figure 7D and 7E, p110γ expression is markedly diminished in pulmonary vascular ECs from patients with ARDS.
p110γ-Mediated FoxM1 Expression in ECs Is Activated by Stromal Cell-Derived Factor-1α Signaling
Unlike other class I PI3K isoforms, p110γ is GPCR dependent. [23] [24] [25] To determine which GPCR signaling activates p110γ and thereby induces FoxM1 expression in ECs, human lung microvascular ECs were treated with 2 well-known GPCR agonists: stromal cell-derived factor-1α (SDF-1α; also called CXCL12) and sphingosine-1-phosphate. As shown in Figure 8A , SDF-1α induced FoxM1 expression in ECs. However, sphingosine-1-phosphate had no effect on FoxM1 expression (data not shown). Inhibition of p110γ but not p110β blocked SDF-1α-induced FoxM1 expression ( Figure 8B ).
Next, we examined the signaling mediator downstream of p110γ. FoxO is inactivated by PI3K through phosphorylationinduced translocation out of nucleus. 36 As shown in Figure 8C , SDF-1α treatment induced FoxO1 translocation out of nucleus in a p110γ-dependent manner. Thus, we determined whether FoxO1 is a negative regulator of p110γ-dependent FoxM1 expression. Cotreatment with p110γ inhibitor and the FoxO1-selective inhibitor AS1842856 37 reversed p110γ inhibitionmediated blockade of SDF-1α-induced FoxM1 expression, whereas the FoxO1 activator psammaphysene A, which inhibits FoxO1 nuclear export, 38 inhibited SDF-1α-induced FoxM1 expression ( Figure 8D ).
To determine whether SDF-1α was induced in mouse lungs responsible for activation of p110γ in vivo, we examined SDF-1α mRNA expression in WT mouse lungs at different times after LPS challenge. SDF-1α was initially decreased and then returned to basal levels at 24 hours after LPS challenge ( Figure 8E ). Importantly, SDF-1α expression was markedly induced at 48 hours after LPS challenge during the recovery phase ( Figure 8E ), indicating the important role of SDF-1α signaling-activated p110γ in mediating FoxM1 expression and thereby endothelial regeneration after inflammatory vascular injury ( Figure 8F ). 
Discussion
We have identified a novel function of p110γ expressed in ECs in mediating endothelial regeneration and vascular repair through the activation of the endothelial reparative transcription factor FoxM1. We showed that endothelial p110γ activation after endotoxemia-induced vascular injury was required for FoxM1 activation and the resulting repair of the endothelial barrier. We also identified SDF-1α as a critical agonist to activate the GPCR-dependent p110γPI3K and thus to induce FoxM1 expression in ECs through inactivation of FoxO1. The finding that p110γ expression was reduced in pulmonary vascular ECs of patients with ARDS suggests that impaired p110γ function itself is a fundamental determinant of persistent lung vascular leakiness and the poorly resolving inflammation seen in these patients.
We have previously shown a role of FoxM1 in ECs in mediating endothelial regeneration and vascular repair. 11, 15 Because little is known about the upstream signaling mechanisms mediating FoxM1 induction in ECs, we focused here on the PI3K isoform p110γ, which was found to have reduced expression in pulmonary vascular ECs of ARDS patients. Several lines of evidence in the present study support the requirement of endothelial p110γ in mediating FoxM1 expression and the resultant vascular repair. Treatment of mice with the p110γ inhibitor AS-605240 at 12 hours after LPS challenge (ie, after the induction of lung inflammation and vascular injury) markedly decreased FoxM1 expression in mouse lungs and failed to restore vascular integrity. In addition, FoxM1 activation was blocked in Pik3cg −/− mouse lungs in response to LPS challenge, and this was accompanied by persistent lung inflammation and vascular injury. Endothelium-specific expression of p110γ in lung vessels of Pik3cg −/− mouse was sufficient to induce FoxM1 expression and to activate vascular repair. These data collectively suggest that activation of endothelial p110γ mediates FoxM1 expression in ECs and thereby activates the endothelial regeneration and vascular repair program after sepsis-induced inflammatory vascular injury.
Consistent with our observation, a previous study has shown that PI3K signaling is involved in the regulation of FoxM1 expression in cancer cells. 39 Overexpression of epidermal growth factor receptor pathway substrate 8 induces FoxM1 expression in cancer cells through PI3K activation. However, the specific PI3K isoform was never identified. The present study provides clear evidence that FoxM1 is induced in the pulmonary vasculature in a p110γ-dependent manner after inflammatory vascular injury. Our studies demonstrate that the GPCR agonist SDF-1α is a critical upstream activator of the GPCR-dependent PI3K isoform p110γ in human lung ECs. Activation of p110γ results in FoxO1 nuclear export and inactivation and thus induction of FoxM1 expression. We observed that inhibition of FoxO1 reversed p110γ inhibition-mediated blockade of SDF-1α-induced FoxM1 expression, whereas inhibition of FoxO1 nuclear export, that is, activation of FoxO1, inhibited SDF-1α-induced FoxM1 expression in ECs. Importantly, SDF-1α is induced in mouse lungs only in the recovery phase after LPS challenge. A recent study has shown that p110γ cooperating with the class II PI3K-C2β plays a role in sphingosine-1-phosphate-induced EC migration. 40 However, we observed no induction of FoxM1 expression in ECs by sphingosine-1-phosphate. Thus, sphingosine-1-phosphate is not the upstream activator of p110γ to activate FoxM1-dependent endothelial regeneration. Taken together, our data suggest an important role of SDF-1α signaling in activating the GPCR-dependent p110γPI3K and thereby promoting FoxM1-dependent endothelial regeneration and vascular repair.
Highly expressed in hematopoietic cells, 41 p110γ regulates the early phase of transendothelial leukocyte migration occurring within minutes to hours. 42, 43 Consistently, we also observed an early (2 hours after LPS) decrease in neutrophil infiltration in Pik3cg −/− mouse lungs. However, the subsequent neutrophil uptake in Pik3cg −/− mouse lungs (up to 24 hours after LPS) was the same as in WT lungs. This increase paralleled the vascular permeability values at this time in both groups. At 48 and 72 hours after LPS, the increases in neutrophil uptake persisted in Pik3cg −/− mouse lungs in which vascular permeability was also increased, whereas neutrophil uptake was restored to basal levels in WT mouse lungs in which permeability had fully recovered. Restoring the expression of either p110γ or FoxM1 in ECs of Pik3cg −/− mouse lungs fully normalized vascular repair and resolved lung inflammation. Given that FoxM1 is essential for endothelial regeneration, 11 the impaired resolution of lung inflammation in Pik3cg −/− mouse lungs is likely the result of failure of vascular integrity to recover in these lungs. In support of the concept that recovery of endothelial barrier function is required to resolve lung inflammation, studies have shown a strong causal relationship between leakiness of the microvessel barrier and transendothelial migration of neutrophils.
2,44,45 Additionally, we observed elevated mRNA levels of intracellular adhesion molecule-1, induced nitric oxide synthase, and various proinflammatory mediators (tumor necrosis factor-α and interleukin-6) in Pik3cg −/− mouse lungs at 48 hours after LPS, in contrast to Pg −/− /Tg mouse lungs. Because these proinflammatory pathways are not the direct transcriptional targets of FoxM1, it is unlikely that the persistent lung inflammation seen in Pik3cg −/− mouse lungs was the result of activation of these pathways. Our results support the essential role of impaired p110γ-FoxM1 signaling as being responsible for the defective vascular repair and thus the impaired resolution of inflammation.
Using the mouse model of ALI induced by intratracheal instillation of LPS, Kim et al 46 observed decreased lung inflammation and vascular permeability in mice pretreated with the p110γ inhibitor AS605240. The discrepancy of this observation with ours may be ascribed to the different models of lung injury. In contrast to systemic administration of LPS, which induces systemic inflammation and multiple organ injury, intratracheal instillation of LPS-induced injury is limited in the lung. Because p110γ plays a critical role in neutrophil recruitment and migration, pretreatment with AS605240 to inhibit p110γ impairs neutrophil infiltration into the lung and thus may result in reduced lung inflammation and vascular injury in the lung injury model induced by intratracheal instillation of LPS. Consistent with the findings in LPS-induced endotoxemia, we also observed that p110γ deficiency impairs endothelial regeneration and induces persistent lung vascular injury and sustained lung inflammation, as well as increased mortality, after CLP-induced polymicrobial sepsis. In agreement with our observation, previous studies have shown that PI3K signaling plays an important protective role in the response to polymicrobial sepsis. 47, 48 Inhibition of PI3K with pan-PI3K inhibitors (wortmannin or LY294002) results in increased susceptibility to polymicrobial sepsis in CLP mice and induces a marked increase in mortality. 47, 48 Maus et al 49 observed increased lung injury in and mortality of Pik3cg −/− mice after pneumococcal infection. However, Martin et al 50 demonstrated that p110γ deficiency or p110γ inhibition reduces multiorgan damage and improves survival. In the present study, we showed that p110γ was indispensable for endothelial regeneration and vascular repair after injury induced by endotoxemia and polymicrobial sepsis. For the first time, our studies have identified FoxM1 as the critical downstream effector of endothelial p110γ. We have shown that transgenic expression of FoxM1 normalizes vascular repair and reduces CLPinduced mortality. Importantly, we also observed decreased p110γ expression in the pulmonary vascular ECs of patients with ARDS, supporting the concept that an impaired p110γ-FoxM1 endothelial regeneration signaling pathway is a critical factor in persistent leaky lung microvessels and edema formation in the disease.
Conclusions
Our studies provide unequivocal evidence that endothelial p110γ is required for FoxM1 expression in ECs in vivo and thereby mediates the endothelial regeneration and vascular repair program after sepsis-induced inflammatory vascular injury. Our data also showed decreased expression of p110γ in pulmonary vascular ECs of patients with ARDS. Thus, activation of p110γ signaling may represent a novel therapeutic strategy for restoring vascular integrity and resolving lung inflammation associated with ALI/ARDS. 
CLINICAL PERSPECTIVE
The integrity of endothelial monolayer is essential for vascular homeostasis. However, little is known about the signaling pathways regulating regeneration of the endothelial barrier after inflammatory vascular injury. In this study, we have identified a novel function of p110γPI3K expressed in endothelial cells in mediating endothelial regeneration and vascular repair. We showed that endothelial p110γ activation by G protein-coupled receptor signaling after sepsis-induced vascular injury was required for Forkhead box M1 (FoxM1) activation and the resulting repair of the endothelial barrier and resolution of inflammation. Our data also provide evidence of the clear association of acute respiratory distress syndrome with diminished expression of p110γPI3K in pulmonary vascular endothelial cells of patients with acute respiratory distress syndrome. Thus, development of means of activation of p110γPI3k-Forkhead box M1 (FoxM1) signaling may represent a novel strategy for the treatment of inflammatory vascular diseases such as acute lung injury or acute respiratory distress syndrome.
Supplemental Material
Online Supplement Methods Induction of polymicrobial sepsis. Polymicrobial sepsis was induced by CLP using a 21-gauge needle. 1,2 Briefly, mice were anesthetized with inhaled isofluorane (2.5% mixed with room air) and subject to either CLP involved two 20-gauge punctures or laparotomy surgery (sham control). When the mouse failed to respond to paw pinch, buprenex (0.1 mg/kg) was administered subcutaneously prior to proper sterilization of the skin with providone iodine, and then a midline abdominal incision was made. The cecum was exposed and ligated with a 3-0 silk tie 1 cm from the tip and the cecal wall was perforated with a 20-gauge needle. Control mice underwent anesthesia, laparotomy, and wound closure but no cecal ligation and puncture.
Immediately following the procedure, 500ul of warmed normal saline was administered subcutaneously. Within 5min following surgery, the mice were able to wake from anesthesia. The mice received a second dose of buprenex at 6-8h post-surgery subcutaneously.
Myeloperoxidase assay. Lung tissues were homogenized in 5 mM phosphate buffer and then centrifuged at 15,000 ×g for 20 minutes at 4°C. The pellets were resuspended in phosphate buffer containing 0.5% hexadecyl trimethylammonium bromide and subjected to a cycle of freezing and thawing. Subsequently the pellets were homogenized and the homogenates were centrifuged again. The supernatants were assayed for MPO activity using kinetics readings for 3 minutes and absorbance was measured at 460 nm. The results were presented as ΔOD 460 /min/g lung tissue.
Lung transvascular albumin flux assessment. Evans blue-albumin (EBA) flux assay was performed as described. [3] [4] [5] EBA at a dose of 20 mg/kg BW was retroorbitally injected into mice 40min before tissue collection. Lungs were perfused free of blood with PBS, blotted dry, weighed and snap frozen in liquid nitrogen. The right lung was homogenized in 1 ml PBS and incubated with 2 volumes of formamide at 60°C for 18h. Then the homogenate was centrifuged at 5,000 × g for 30min. The optical density of the supernatant was determined at 620 nm and 740 nm. Extravasated EBA in lung homogenates was expressed as micrograms of Evans blue dye per g lung tissue.
Scanning electron microscopy. Preparation of lung tissues for scanning electron microscopy was following the procedure described previously. 6 Briefly, mice were anesthetized and the pulmonary artery was cannulated with an 18-gauge catheter. Then 2 mL of partially polymerized methyl methacrylate (Mercox; Ladd Research Industries) mixed with benzoyl peroxide (accelerator) was injected into the lung over 2 min using a Harvard Pump. The methacrylate resin was allowed to harden overnight. The tissue was macerated in sodium hydroxide solution for at least 2 weeks with daily changes of the bath. The casts were cut and mounted on aluminum studs, sputter-coated with palladium-gold, and imaged with a Hitachi S-3000N scanning electron microscope at 10kV.
Intravital microscopy. Intravital microscopy of the mouse cremaster muscle circulation was performed as previously described. 7 At 48h post-LPS challenged (7.5 mg/kg BW, i.p.), the mice were anesthetized, and FITC-conjugated dextran (MW= 20kD, 1 mg/kg BW, Sigma) was injected through jugular cannulus. The scrotum was incised at 30 min after FITC-dextran administration, the surrounding cremaster muscle were exteriorized onto an intravital microscopy tray. Then the cremaster muscle was superfused with thermo-controlled (37°C) and aerated (95% N 2 and 5% CO 2 ) biocarbonate-buffered saline. For the permeability measurements, images were recorded using an Olympus BX61W microscope with 60 x/0.9 NA water immersion objective lens and a high speed camera (Hamamatsu C9300) through an intensifier (Video Scope To exclude potential cofounding effect of p110 inhibition on leukocytes recruitment in the initial responses, p110 inhibitor, AS-605240 (30mg/kg BW, per os, every 12h) was administered into WT mice at 12h post-LPS challenge (7.5 mg/kg, i.p). 0.5% carboxymethycellulose/0.25% Tween-20 was used as vehicle control. At 24h or 48h post-LPS challenge, lungs were perfused free of blood with PBS and collected for EBA assay. Data are expressed as mean ± SD (n = 5). *, P < 0.01 (t test). (B) MPO activity assay revealing sustained elevation of lung inflammation in mice treated with p110 inhibitor. *, P < 0.01 (t test). 
